Cardiac Implantable Devices (CID) Guidelines

This policy covers cardiac implantable devices and related imaging/assessment including permanent and leadless pacemakers, implantable cardioverter‑defibrillators (ICDs), cardiac resynchronization therapy devices (CRT‑P/CRT‑D and wireless variants), and other implants such as wireless pulmonary artery pressure sensors. It applies to patients meeting defined indications (e.g., NYHA heart‑failure classes, arrhythmia indications, abnormal exercise BP responses) but excludes atypical presentations requiring physician review; major requirements include adherence to definite/reasonable indication criteria, stated non‑indications for specific devices, and prior optimization of medical therapy (typically ≥3 months of maximally tolerated beta‑blocker, ACE inhibitor/ARB and diuretic therapy, with ambulatory Class IV CHF requiring no acute coronary syndrome, no inotropes, and being on guideline‑directed medical therapy).

"Other Cardiac Implantable Devices"